European Heart Journal Advance Access published online on June 14, 2007
European Heart Journal, doi:10.1093/eurheartj/ehm161
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes,
The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
Authors/Task Force Members,
France
Germany
Italy
The Netherlands
Poland
Spain
UK
Israel
USA
Sweden
Belgium
ESC Committee for Practice Guidelines (CPG),
France
UK
Italy
France
Norway
Greece
Denmark
Czech Republic
France
Germany
Poland
The Netherlands
Spain
Germany
France
Document Reviewers,
Denmark
Italy
Austria
France
Spain
Italy
Belgium
Germany
Spain
Germany
Israel
Austria
Israel
Spain
Portugal
Norway
Germany
France
Denmark
Italy
Canada
The Netherlands
Switzerland
* Corresponding authors. Chair: Jean-Pierre Bassand, Department of Cardiology, University Hospital Jean Minjoz, Boulevard Fleming, 25000 Besançon, France. Tel: +33 381 668 539; fax: +33 381 668 582. E-mail address: jean-pierre.bassand@ufc-chu.univ-fcomte.fr Co-chair: Christian W. Hamm Kerckhoff Heart Center, Benekestr. 2-8, 61231 Bad Nauheim, Germany. Tel: +49 6032 996 2202; fax: +49 6032 996 2298. E-mail address: c.hamm@kerckhoff-klinik.de
| The first 150 words of the full text of this article appear below. |
| Preamble |
|---|
Guidelines and Expert Consensus Documents summarize and evaluate all currently available evidence on a particular issue with the aim to assist physicians in selecting the best management strategies for a typical patient, suffering from a given condition, taking into account the impact on outcome, as well as the riskbenefit ratio of particular diagnostic or therapeutic means. Guidelines are no substitutes for textbooks. The legal implications of medical guidelines have been discussed previously.
A great number of Guidelines and Expert Consensus Documents have been issued in recent years by the European Society of Cardiology (ESC) as well as by other societies and organizations. Because of the impact on clinical practice, quality criteria for development of guidelines have been established in order to make all decisions transparent to the user. The recommendations for formulating and issuing ESC Guidelines and Expert Consensus Documents can be found on the ESC website (http://www.escardio.org/knowledge/guidelines/rules).
| 1. Introduction and definitions |
|---|
| 2. Epidemiology and natural history |
|---|
| 3. Pathophysiology |
|---|
3.1 The vulnerable plaque
3.2 Coronary thrombosis
3.3 The vulnerable patient
3.4 Endothelial vasodilatory dysfunction
3.5 Accelerated atherosclerosis
3.6 Secondary mechanisms
3.7 Myocardial injury
| 4. Diagnosis and risk assessment |
|---|
4.1 Clinical presentation and history
4.2 Diagnostic tools
4.2.1 Physical examination
4.2.2 Electrocardiogram
Continuous ST-segment monitoring
Exercise or other stress testing
4.2.3 Biochemical markers
Markers of myocardial injury
Markers of inflammatory activity
Markers of neurohumoral activation
Markers of renal function
Novel biomarkers
Multimarker approach
Point-of-care (bedside) biomarker testing
4.2.4 Echocardiography and non-invasive myocardial imaging
4.2.5 Imaging of the coronary anatomy
4.3 Differential diagnoses
4.4 Risk scores
| 5. Treatment |
|---|
5.1 Anti-ischaemic agents
5.1.1 Beta-blockers
5.1.2 Nitrates
5.1.3 Calcium channel blockers
5.1.4 New drugs
5.2 Anticoagulants
5.2.1 Unfractionated heparin
Pharmacology
Treatment effects
5.2.2 Low molecular weight heparin
Pharmacology
Treatment effects
5.2.3 Factor-Xa inhibitors
Pharmacology
Treatment effects
5.2.4 Direct thrombin inhibitors
Pharmacology
Treatment effects
5.2.5 Vitamin K antagonists
5.2.6 Anticoagulants during percutaneous coronary intervention procedures in non-ST-segment elevation acute coronary syndromes
5.3 Antiplatelet agents
5.3.1 Acetylsalicylic acid (aspirin)
5.3.2 Thienopyridines
Risk of bleeding
Dose and timing of clopidogrel
5.3.3 Glycoprotein IIb/IIIa receptor inhibitors
Glycoprotein IIb/IIIa inhibitors in a conservative strategy
Glycoprotein IIb/IIIa inhibitors in an invasive strategy
Use of glycoprotein IIb/IIIa inhibitors prior to revascularization
Adjunctive therapy
5.3.4 Resistance to antiplatelet agents/drug interactions
Aspirin resistance/drug interactions
Clopidogrel resistance/drug interactions
5.3.5 Withdrawal of antiplatelet agents
5.4 Coronary revascularization
5.4.1 Coronary angiography
5.4.2 Invasive vs. conservative strategy
Choice of strategy
Timing of invasiveness
5.4.3 Percutaneous coronary intervention
5.4.4 Coronary artery bypass graft
5.4.5 Respective indications for percutaneous coronary intervention or coronary artery bypass graft
5.5 Long-term management
5.5.1 Lifestyle
5.5.2 Weight reduction
5.5.3 Blood pressure control
5.5.4 Management of diabetes
5.5.5 Interventions on lipid profile
Statins
Other lipid-lowering agents
5.5.6 Antiplatelet agents and anticoagulants
5.5.7 Beta-blockers
5.5.8 Angiotensin-converting enzyme inhibitors
5.5.9 Angiotensin-2 receptor blockers
5.5.10 Aldosterone receptor antagonists
5.6 Rehabilitation and return to physical activity
| 6. Complications and their management |
|---|
6.1 Bleeding complications
6.1.1 Predictors of bleeding risk
6.1.2 Impact of bleeding on prognosis
6.1.3 Management of bleeding complications
6.1.4 Impact of blood transfusion
6.2 Thrombocytopenia
6.2.1 Heparin-induced thrombocytopenia
6.2.2 Glycoprotein IIb/inhibitor-induced thrombocytopenia
| 7. Special populations and conditions |
|---|
7.1 The elderly
7.1.1 Early diagnostic evaluation in the elderly
7.1.2 Therapeutic considerations
7.2 Gender
7.2.1 Glycoprotein IIb/IIIa inhibitors in women
7.2.2 Revascularization and early invasive strategy among women
7.3 Diabetes mellitus
7.4 Chronic kidney disease
7.4.1 Chronic kidney disease as a marker of risk of coronary artery disease
7.4.2 Contrast-induced nephropathy
7.4.3 Management of chronic kidney disease in patients with coronary artery disease
7.4.4 Biomarkers in chronic kidney disease
7.5 Anaemia
7.6 Normal coronary arteries
| 8. Management strategies |
|---|
8.1 First step: initial evaluation
8.2 Second step: diagnosis validation and risk assessment
8.2.1 Diagnosis validation
8.2.2 Risk assessment
8.3 Third step: invasive strategy
8.3.1 Conservative strategy
8.3.2 Urgent invasive strategy
8.3.3 Early invasive strategy
8.4 Fourth step: revascularization modalities
8.5 Fifth step: discharge and post-discharge management
| 9. Performance measures |
|---|
| 10. Abbreviations |
|---|
| 11. Trial acronyms |
|---|
This article has been cited by other articles:
![]() |
G. Ambrosio, M. Del Pinto, I. Tritto, G. Agnelli, M. Bentivoglio, C. Zuchi, F. A. Anderson, J. M. Gore, J. Lopez-Sendon, A. Wyman, et al. Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52 693 patients in the Global Registry of Acute Coronary Events Eur. Heart J., November 10, 2009; (2009) ehp457v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. van Werkhoven, J. D. Schuijf, O. Gaemperli, J. W. Jukema, L. J. Kroft, E. Boersma, A. Pazhenkottil, I. Valenta, G. Pundziute, A. de Roos, et al. Incremental prognostic value of multi-slice computed tomography coronary angiography over coronary artery calcium scoring in patients with suspected coronary artery disease Eur. Heart J., November 1, 2009; 30(21): 2622 - 2629. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Kaski C-reactive protein improves risk prediction in patients with acute coronary syndrome, or does it? Eur. Heart J., October 23, 2009; (2009) ehp435v1. [Full Text] [PDF] |
||||
![]() |
J.-P. Bassand, R. Afzal, J. Eikelboom, L. Wallentin, R. Peters, A. Budaj, K. A.A. Fox, C. D. Joyner, S. Chrolavicius, C. B. Granger, et al. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes Eur. Heart J., October 12, 2009; (2009) ehp401v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Morrissey, G. A. Diamond, and S. Kaul Statins in Acute Coronary Syndromes: Do the Guideline Recommendations Match the Evidence? J. Am. Coll. Cardiol., October 6, 2009; 54(15): 1425 - 1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
J S Birkhead, C F M Weston, and R Chen Determinants and outcomes of coronary angiography after non-ST-segment elevation myocardial infarction. A cohort study of the Myocardial Ischaemia National Audit Project (MINAP) Heart, October 1, 2009; 95(19): 1593 - 1599. [Abstract] [Full Text] [PDF] |
||||
![]() |
J M van Werkhoven, O Gaemperli, J D Schuijf, J W Jukema, L J Kroft, S Leschka, H Alkadhi, I Valenta, G Pundziute, A de Roos, et al. Multislice computed tomography coronary angiography for risk stratification in patients with an intermediate pretest likelihood Heart, October 1, 2009; 95(19): 1607 - 1611. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wallentin, R. C. Becker, A. Budaj, C. P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, et al. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes N. Engl. J. Med., September 10, 2009; 361(11): 1045 - 1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Bonaca, P. G. Steg, L. J. Feldman, J. F. Canales, J. J. Ferguson, L. Wallentin, R. M. Califf, R. A. Harrington, and R. P. Giugliano Antithrombotics in acute coronary syndromes. J. Am. Coll. Cardiol., September 8, 2009; 54(11): 969 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Szummer, P. Lundman, S. H. Jacobson, S. Schon, J. Lindback, U. Stenestrand, L. Wallentin, T. Jernberg, and for SWEDEHEART Influence of Renal Function on the Effects of Early Revascularization in Non-ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) Circulation, September 8, 2009; 120(10): 851 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Cannon Should We Manage Patients With Non-ST Segment Elevation Myocardial Infarction With Renal Failure With an Invasive Strategy? Circulation, September 8, 2009; 120(10): 828 - 830. [Full Text] [PDF] |
||||
![]() |
G. Montalescot, G. Cayla, J.-P. Collet, S. Elhadad, F. Beygui, H. Le Breton, R. Choussat, F. Leclercq, J. Silvain, F. Duclos, et al. Immediate vs Delayed Intervention for Acute Coronary Syndromes: A Randomized Clinical Trial JAMA, September 2, 2009; 302(9): 947 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
R K Riezebos, G J Laarman, and J G P Tijssen The authors' reply Heart, September 1, 2009; 95(17): 1456 - 1456. [Full Text] [PDF] |
||||
![]() |
K E Joynt, L Huynh, J V Amerena, D B Brieger, S G Coverdale, J M Rankin, A Soman, and D P Chew Impact of acute and chronic risk factors on use of evidence-based treatments in patients in Australia with acute coronary syndromes Heart, September 1, 2009; 95(17): 1442 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Melloni and L K. Newby Risk factor management after acute coronary syndromes Heart, September 1, 2009; 95(17): 1382 - 1384. [Full Text] [PDF] |
||||
![]() |
T. Reichlin, W. Hochholzer, S. Bassetti, S. Steuer, C. Stelzig, S. Hartwiger, S. Biedert, N. Schaub, C. Buerge, M. Potocki, et al. Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays N. Engl. J. Med., August 27, 2009; 361(9): 858 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Damman, J. Tijssen, R. de Winter, B. Rathod, A. Cequier, J. A. Gomez-Hospital, J. Gonzalez-Costello, S. Shojai, S. R. Mehta, S. Yusuf, et al. Acute Coronary Syndromes N. Engl. J. Med., August 27, 2009; 361(9): 925 - 927. [Full Text] [PDF] |
||||
![]() |
M. O'Donoghue, E. M. Antman, E. Braunwald, S. A. Murphy, P. G. Steg, A. Finkelstein, W. F. Penny, V. Fridrich, C. H. McCabe, M. S. Sabatine, et al. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) Analysis. J. Am. Coll. Cardiol., August 18, 2009; 54(8): 678 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
N C Edwards, H Routledge, and R P Steeds T2-weighted magnetic resonance imaging to assess myocardial oedema in ischaemic heart disease Heart, August 15, 2009; 95(16): 1357 - 1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Di Sciascio, G. Patti, V. Pasceri, A. Gaspardone, G. Colonna, and A. Montinaro Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention: Results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial J. Am. Coll. Cardiol., August 4, 2009; 54(6): 558 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Lopes, L. E. Elliott, H. D. White, J. S. Hochman, F. Van de Werf, D. Ardissino, T. T. Nielsen, W. D. Weaver, P. Widimsky, P. W. Armstrong, et al. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial Eur. Heart J., August 2, 2009; 30(16): 2019 - 2028. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wallentin P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use Eur. Heart J., August 2, 2009; 30(16): 1964 - 1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Steg Heart rate management in coronary artery disease: the CLARIFY registry Eur. Heart J. Suppl., August 1, 2009; 11(suppl_D): D13 - D18. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Jolly, D. P. Faxon, K. A.A. Fox, R. Afzal, W. E. Boden, P. Widimsky, P. G. Steg, V. Valentin, A. Budaj, C. B. Granger, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial. J. Am. Coll. Cardiol., July 28, 2009; 54(5): 468 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P Gale, A. D Simms, B. A Cattle, D. Greenwood, and R. M West Point of care testing in acute coronary syndromes: when and how? Heart, July 15, 2009; 95(14): 1128 - 1129. [Full Text] [PDF] |
||||
![]() |
F. Schiele, N. Meneveau, M. F. Seronde, R. Chopard, V. Descotes-Genon, J. Dutheil, J.-P. Bassand, and on behalf on the 'Reseau de Cardiologie de Franche C-reactive protein improves risk prediction in patients with acute coronary syndromes Eur. Heart J., July 4, 2009; (2009) ehp273v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Van de Werf New antithrombotic agents: are they needed and what can they offer to patients with a non-ST-elevation acute coronary syndrome? Eur. Heart J., July 2, 2009; 30(14): 1695 - 1702. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Chan, J. L. Sun, L. K. Newby, L. K. Shaw, M. Lin, E. D. Peterson, R. M. Califf, D. F. Kong, and M. T. Roe Long-Term Mortality of Patients Undergoing Cardiac Catheterization for ST-Elevation and Non-ST-Elevation Myocardial Infarction Circulation, June 23, 2009; 119(24): 3110 - 3117. [Abstract] [Full Text] [PDF] |
||||
![]() |
C P Gale, S O M Manda, B A Cattle, C F Weston, J S Birkhead, P D Batin, A S Hall, and R M West The authors' reply: Heart, June 15, 2009; 95(12): 1019 - 1020. [Full Text] [PDF] |
||||
![]() |
APPRAISE Steering Committee and Investigators Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome: Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial Circulation, June 9, 2009; 119(22): 2877 - 2885. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Brieger, K A A Fox, G FitzGerald, K A Eagle, A Budaj, A Avezum, C B Granger, B Costa, F A Anderson Jr, P. G Steg, et al. Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events Heart, June 1, 2009; 95(11): 888 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Windhausen, A. Hirsch, J. Fischer, P. M. van der Zee, G. T. Sanders, J. P. van Straalen, J. H. Cornel, J. G.P. Tijssen, F. W.A. Verheugt, R. J. de Winter, et al. Cystatin C for Enhancement of Risk Stratification in Non-ST Elevation Acute Coronary Syndrome Patients with an Increased Troponin T Clin. Chem., June 1, 2009; 55(6): 1118 - 1125. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Astroulakis and J. M. Hill Does 'SWITCHing' from heparin to bivalirudin monotherapy result in a bleeding benefit? Eur. Heart J. Suppl., June 1, 2009; 11(suppl_C): C13 - C18. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Mehta, C. B. Granger, W. E. Boden, P. G. Steg, J.-P. Bassand, D. P. Faxon, R. Afzal, S. Chrolavicius, S. S. Jolly, P. Widimsky, et al. Early versus Delayed Invasive Intervention in Acute Coronary Syndromes N. Engl. J. Med., May 21, 2009; 360(21): 2165 - 2175. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Hillis and R. A. Lange Optimal Management of Acute Coronary Syndromes N. Engl. J. Med., May 21, 2009; 360(21): 2237 - 2240. [Full Text] [PDF] |
||||
![]() |
R. P. Giugliano, J. A. White, C. Bode, P. W. Armstrong, G. Montalescot, B. S. Lewis, A. van `t Hof, L. G. Berdan, K. L. Lee, J. T. Strony, et al. Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes N. Engl. J. Med., May 21, 2009; 360(21): 2176 - 2190. [Abstract] [Full Text] [PDF] |
||||
![]() |
R K Riezebos and G J Laarman The authors' reply: Heart, May 1, 2009; 95(9): 761 - 761. [Full Text] [PDF] |
||||
![]() |
K. A A Fox COURAGE to change practice? Revascularisation in patients with stable coronary artery disease Heart, May 1, 2009; 95(9): 689 - 692. [Full Text] [PDF] |
||||
![]() |
R K Riezebos, E Ronner, E ter Bals, T Slagboom, P C Smits, J M ten Berg, F Kiemeneij, G Amoroso, M S Patterson, M J Suttorp, et al. Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes Heart, May 1, 2009; 95(10): 807 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Scirica, D. A. Morrow, A. Budaj, A. J. Dalby, S. Mohanavelu, J. Qin, J. Aroesty, C. M. Hedgepeth, P. H. Stone, and E. Braunwald Ischemia Detected on Continuous Electrocardiography After Acute Coronary Syndrome: Observations From the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) Trial J. Am. Coll. Cardiol., April 21, 2009; 53(16): 1411 - 1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chua and A. Ignaszewski Clopidogrel in acute coronary syndromes BMJ, April 14, 2009; 338(apr14_1): b1180 - b1180. [Full Text] |
||||
![]() |
J. L. Anderson Stopping the Hemorrhage: A New Baseline Bleeding Score Brings Us a Step Closer for Patients With Non-ST-Elevation Myocardial Infarction Circulation, April 14, 2009; 119(14): 1846 - 1849. [Full Text] [PDF] |
||||
![]() |
S. Subherwal, R. G. Bach, A. Y. Chen, B. F. Gage, S. V. Rao, L. K. Newby, T. Y. Wang, W. B. Gibler, E. M. Ohman, M. T. Roe, et al. Baseline Risk of Major Bleeding in Non-ST-Segment-Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score Circulation, April 14, 2009; 119(14): 1873 - 1882. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schiele, N. Meneveau, M. F. Seronde, V. Descotes-Genon, J. Oettinger, F. Ecarnot, J.-P. Bassand, and on behalf of the 'Reseau de Cardiologie de Franche Changes in management of elderly patients with myocardial infarction Eur. Heart J., April 2, 2009; 30(8): 987 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Z. Potsis, C. Katsouras, and J. A. Goudevenos Avoiding and Managing Bleeding Complications in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Angiology, April 1, 2009; 60(2): 148 - 158. [Abstract] [PDF] |
||||
![]() |
D. L. BHATT, K. KOTTKE-MARCHANT, J. H. ALEXANDER, W. F. PEACOCK, and M. S. SABATINE Platelet response in practice: Applying new insights and tools for testing and treatment Cleveland Clinic Journal of Medicine, April 1, 2009; 76(Suppl_1): S24 - S32. [Full Text] [PDF] |
||||
![]() |
D J Kurz, A Bernstein, K Hunt, D Radovanovic, P Erne, Z Siudak, and O Bertel Simple point-of-care risk stratification in acute coronary syndromes: the AMIS model Heart, April 1, 2009; 95(8): 662 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hirsch, F. Windhausen, J. G.P. Tijssen, A. J.M. Oude Ophuis, W. J. van der Giessen, P. M. van der Zee, J. H. Cornel, F. W.A. Verheugt, R. J. de Winter, and for the Invasive versus Conservative Treatment in Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias Eur. Heart J., March 2, 2009; 30(6): 645 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tricoci, J. M. Allen, J. M. Kramer, R. M. Califf, and S. C. Smith Jr Scientific Evidence Underlying the ACC/AHA Clinical Practice Guidelines JAMA, February 25, 2009; 301(8): 831 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Yan, R. T. Yan, T. Huynh, A. Casanova, F. E. Raimondo, D. H. Fitchett, A. Langer, S. G. Goodman, and for the Canadian Acute Coronary Syndrome Registry Understanding Physicians' Risk Stratification of Acute Coronary Syndromes: Insights From the Canadian ACS 2 Registry Arch Intern Med, February 23, 2009; 169(4): 372 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. van Werkhoven, J. D. Schuijf, O. Gaemperli, J. W. Jukema, E. Boersma, W. Wijns, P. Stolzmann, H. Alkadhi, I. Valenta, M. P.M. Stokkel, et al. Prognostic value of multislice computed tomography and gated single-photon emission computed tomography in patients with suspected coronary artery disease. J. Am. Coll. Cardiol., February 17, 2009; 53(7): 623 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Aoki, A. J. Lansky, R. Mehran, J. Moses, M. E. Bertrand, B. T. McLaurin, D. A. Cox, A. M. Lincoff, E. M. Ohman, H. D. White, et al. Early Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Drug-Eluting and Bare Metal Stents: The Acute Catheterization and Urgent Intervention Triage Strategy Trial Circulation, February 10, 2009; 119(5): 687 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Body, S Carley, G McDowell, J Ferguson, and K Mackway-Jones Can a modified thrombolysis in myocardial infarction risk score outperform the original for risk stratifying emergency department patients with chest pain? Emerg. Med. J., February 1, 2009; 26(2): 95 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Swanson, G Montalescot, K A Eagle, S G Goodman, W Huang, D Brieger, G Devlin, and for the GRACE Investigators Delay to angiography and outcomes following presentation with high-risk, non-ST-elevation acute coronary syndromes: results from the Global Registry of Acute Coronary Events Heart, February 1, 2009; 95(3): 211 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.A. Katus, E. Giannitsis, A.S. Jaffe, and K. Thygesen Higher sensitivity troponin assays: Quo vadis? Eur. Heart J., January 2, 2009; 30(2): 127 - 128. [Full Text] [PDF] |
||||
![]() |
A. M. Jansson, H. Rosjo, T. Omland, T. Karlsson, M. Hartford, A. Flyvbjerg, and K. Caidahl Prognostic value of circulating chromogranin A levels in acute coronary syndromes Eur. Heart J., January 1, 2009; 30(1): 25 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Eggers, A. S. Jaffe, L. Lind, P. Venge, and B. Lindahl Value of Cardiac Troponin I Cutoff Concentrations below the 99th Percentile for Clinical Decision-Making Clin. Chem., January 1, 2009; 55(1): 85 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Hamm, H. Möllmann, J.-P. Bassand, and F. van de Werf CHAPTER 16 Acute Coronary Syndromes ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hoeks and D. Poldermans CHAPTER 34 Non-cardiac Surgery in Cardiac Patients ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lordkipanidze, C. Pharand, T. A. Nguyen, E. Schampaert, D. A. Palisaitis, and J. G. Diodati Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients Eur. Heart J., December 1, 2008; 29(23): 2877 - 2885. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, F. Van de Werf, J. Bax, A. Betriu, C. Blomstrom-Lundqvist, F. Crea, V. Falk, G. Filippatos, K. Fox, K. Huber, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology: Eur. Heart J., December 1, 2008; 29(23): 2909 - 2945. [Full Text] [PDF] |
||||
![]() |
S. R. Mehta, W. E. Boden, J. W. Eikelboom, M. Flather, P. G. Steg, A. Avezum, R. Afzal, L. S. Piegas, D. P. Faxon, P. Widimsky, et al. Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non-ST-Segment Elevation Acute Coronary Syndromes: An Individual Patient-Level Combined Analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) Randomized Trials Circulation, November 11, 2008; 118(20): 2038 - 2046. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schmidinger, C. C. Zielinski, U. M. Vogl, A. Bojic, M. Bojic, C. Schukro, M. Ruhsam, M. Hejna, and H. Schmidinger Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma J. Clin. Oncol., November 10, 2008; 26(32): 5204 - 5212. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Jeger, D. Radovanovic, P. R. Hunziker, M. E. Pfisterer, J.-C. Stauffer, P. Erne, P. Urban, and for the AMIS Plus Registry Investigators Ten-Year Trends in the Incidence and Treatment of Cardiogenic Shock Ann Intern Med, November 4, 2008; 149(9): 618 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Tziakas, G. K. Chalikias, I. K. Tentes, D. Stakos, S. V. Chatzikyriakou, K. Mitrousi, A. X. Kortsaris, J. C. Kaski, and H. Boudoulas Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome Eur. Heart J., November 2, 2008; 29(22): 2713 - 2722. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Goran Suggestion to list acute aortic dissection as a possible cause of type 2 myocardial infarction (according to the universal definition) Eur. Heart J., November 2, 2008; 29(22): 2819 - 2820. [Full Text] [PDF] |
||||
![]() |
M. Zimarino and R. De Caterina Long-term treatment strategies for atherothrombotic disease: do platelets define the course? Eur. Heart J. Suppl., November 1, 2008; 10(suppl_I): I8 - I13. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sanz-Ruiz and F. Fernandez-Aviles European perspective on the use of antiplatelet agents in atherothrombotic disease Eur. Heart J. Suppl., November 1, 2008; 10(suppl_I): I14 - I18. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Betriu Clinical implications of the results of recent atherothrombotic trials on patient management Eur. Heart J. Suppl., November 1, 2008; 10(suppl_I): I30 - I32. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Hermansen, M. Hansen, M. Roaldsen, S. Muller, O.-J. How, and T. Myrmel Utilization and outcome of coronary revascularization and valve procedures in acute heart failure - an evaluation based on the classification from the European Society of Cardiology Interactive CardioVascular and Thoracic Surgery, October 1, 2008; 7(5): 833 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Eggers, T. Kempf, T. Allhoff, B. Lindahl, L. Wallentin, and K. C. Wollert Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain Eur. Heart J., October 1, 2008; 29(19): 2327 - 2335. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pundziute, J. D. Schuijf, J. W. Jukema, I. Decramer, G. Sarno, P. K. Vanhoenacker, E. Boersma, J. H.C. Reiber, M. J. Schalij, W. Wijns, et al. Evaluation of plaque characteristics in acute coronary syndromes: non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis Eur. Heart J., October 1, 2008; 29(19): 2373 - 2381. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur. Heart J., October 1, 2008; 29(19): 2388 - 2442. [Full Text] [PDF] |
||||
![]() |
K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, A. W. Hoes, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail, October 1, 2008; 10(10): 933 - 989. [Full Text] [PDF] |
||||
![]() |
R. P. Giugliano and E. Braunwald The Year in Non-ST-Segment Elevation Acute Coronary Syndrome J. Am. Coll. Cardiol., September 23, 2008; 52(13): 1095 - 1103. [Full Text] [PDF] |
||||
![]() |
G. Y H Lip Managing the anticoagulated patient with atrial fibrillation at high risk of stroke who needs coronary intervention BMJ, September 12, 2008; 337(sep12_1): a840 - a840. [Full Text] |
||||
![]() |
P. G. Steg, A. Kerner, F. Van de Werf, J. Lopez-Sendon, J. M. Gore, G. FitzGerald, L. J. Feldman, F. A. Anderson, A. Avezum, and for the Global Registry of Acute Coronary Events ( Impact of In-Hospital Revascularization on Survival in Patients With Non-ST-Elevation Acute Coronary Syndrome and Congestive Heart Failure Circulation, September 9, 2008; 118(11): 1163 - 1171. [Abstract] [Full Text] [PDF] |
||||

















